About Trastuzumab For Injection
Discover the prime solution for targeted cancer therapy with Trastuzumab For Injection, 440mg per vial. This customizable hot deal offers unrivaled value and is an ace option for HER2 positive breast and metastatic gastric cancer. Each vial is supplied with inestimable BWFI diluent, ensuring precise reconstitution and ease of use. Approved by DCGI and supplied from India, this antineoplastic monoclonal antibody therapy is prescription-only and requires administration under oncologist supervision. Experience consistent quality, optimal efficacy, and the guarantee of reliable storage with a life span of 24 months.
Application, Advantage, and Uses of Trastuzumab For Injection
Trastuzumab For Injection is administered via intravenous infusion under strict medical guidance, rendering it highly effective in targeted therapy. Its ace advantage is in providing inestimable benefit for adults diagnosed with HER2 positive breast and metastatic gastric cancer. Specific usage involves customized dosing as directed by an oncologist, typically 6 mg/kg body weight every three weeks after an initial loading dose. General use falls under oncology, contributing to modern antineoplastic treatment regimens.
FOB Port, Delivery, and Certification Information
Trastuzumab For Injection is made available through a reliable distribution network in India, with FOB port services at major outlay points. Each order is swiftly dispatched, guaranteeing prompt drop-off from certified suppliers and traders. The product meets the highest regulatory requirements, having DCGI approval and authentic documentation provided with each shipment, ensuring secure international and domestic distribution.
FAQ's of Trastuzumab For Injection:
Q: How should Trastuzumab For Injection be administered for optimal effectiveness?
A: Trastuzumab For Injection must be administered as an intravenous infusion under medical supervision, following the dosage guidelines prescribed by an oncologist.
Q: What makes this product a customizable hot deal in oncology care?
A: With a prime dose of 440mg per vial and reconstitution flexibility, this product is customizable for individual patient requirements, offering significant value in targeted monoclonal antibody therapy.
Q: When should reconstitution of the injection be performed and with what diluent?
A: Reconstitution should be done immediately before administration using the 20mL bacteriostatic water for injection (BWFI) included in the packaging.
Q: Where is Trastuzumab For Injection manufactured and what certifications does it carry?
A: This product is manufactured in India, distributed by accredited suppliers, and approved by the Drug Controller General of India (DCGI) or equivalent authorities.
Q: What therapeutic benefits does Trastuzumab provide for patients?
A: Trastuzumab delivers targeted therapy for HER2 positive breast cancer and metastatic gastric cancer, improving survival outcomes when administered as recommended.
Q: What are the potential side effects and contraindications of this medication?
A: Possible side effects include fever, chills, nausea, cardiotoxicity, and infusion reactions. It is contraindicated in those with known hypersensitivity to Trastuzumab or its excipients.